BamSEC and AlphaSense Join Forces
Learn More

Abbott Laboratories

NYSE: ABT    
Share price (11/21/24): $117.26    
Market cap (11/21/24): $203 billion
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 6 pages Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 81 pages Stock Purchase Agreement by and Between Abbott Laboratories, Chace LLC and Johnson & Johnson Solely for the Purpose of Section 11.12 Dated as of September 14, 2016
12/34/56
EX-2.1
from 8-K 110 pages Agreement and Plan of Merger Dated as of April 27, 2016 by and Among Abbott Laboratories, St. Jude Medical, Inc., Vault Merger Sub, Inc. and Vault Merger Sub, LLC
12/34/56
EX-2.1
from 425 110 pages Agreement and Plan of Merger Dated as of April 27, 2016 by and Among Abbott Laboratories, St. Jude Medical, Inc., Vault Merger Sub, Inc. and Vault Merger Sub, LLC
12/34/56
EX-2.1
from 8-K 82 pages Agreement and Plan of Merger by and Among Abbott Laboratories and Alere Inc. Dated as of January 30, 2016
12/34/56
EX-2.1
from 10-Q 112 pages Amended and Restated Business Transfer Agreement and Plan of Merger Dated as of November 4, 2014 Between and Among Abbott Laboratories, Mylan Inc., New Moon B.V. and Moon of Pa Inc
12/34/56
EX-2.1
from 10-Q 64 pages Transaction Agreement Between Abbott Investments Luxembourg S.À R.L. and Positron Limited Dated as of May 15, 2014
12/34/56
EX-2.1
from 8-K 73 pages Separation and Distribution Agreement by and Between Abbott Laboratories and Abbvie Inc. Dated as of November 28, 2012
12/34/56
EX-2
from 10-Q 8 pages Amendment No. 2 to Business Transfer Agreement
12/34/56
EX-2.2
from 8-K 34 pages Amendment No. 1 to Business Transfer Agreement
12/34/56
EX-2.1
from 8-K 113 pages Business Transfer Agreement by Piramal Healthcare Limited (Seller) and Abbott Healthcare Private Limited (Purchaser) Dated May 21, 2010
12/34/56
EX-2.2
from 8-K 12 pages Amendment No. 1 to Stock and Asset Purchase Agreement
12/34/56
EX-2.1
from 10-Q 156 pages Stock and Asset Purchase Agreement Among Solvay SA and the Other Sellers Named Herein and Abbott Laboratories and the Other Buyers Named Herein Dated as of September 26, 2009
12/34/56
EX-2.1
from SC TO-C 86 pages Agreement and Plan of Merger by and Among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. Dated as of January 11, 2009
12/34/56
EX-2.1
from 8-K 86 pages Agreement and Plan of Merger by and Among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. Dated as of January 11, 2009
12/34/56
EX-2
from 10-Q 101 pages Contribution and Exchange Agreement by and Among Abbott Laboratories Takeda Pharmaceutical Company Limited Takeda America Holdings, Inc. Tap Pharmaceutical Products Inc. Lake Products Inc. and Takeda Pharmaceuticals LLC Dated as of March 19, 2008
12/34/56
EX-2.1
from 8-K 60 pages Agreement and Plan of Merger Among Abbott Laboratories, S&G Nutritionals, Inc. and Kos Pharmaceuticals, Inc. Dated as of November 5, 2006
12/34/56
EX-2.1
from SC TO-C 60 pages Agreement and Plan of Merger Among Abbott Laboratories, S&G Nutritionals, Inc. and Kos Pharmaceuticals, Inc. Dated as of November 5, 2006
12/34/56
EX-2.6
from 10-K ~5 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 10-Q ~20 pages Fourth Amendment of Purchase Agreement
12/34/56